Literature DB >> 12531221

Determination of T-cell receptors of clonal CD8-positive T-cells in myelodysplastic syndrome with erythroid hypoplasia.

Takaji Matsutani1, Takeshi Yoshioka, Yuji Tsuruta, Takashi Shimamoto, Junko H Ohyashiki, Ryuji Suzuki, Kazuma Ohyashiki.   

Abstract

We determined T-cell receptor alpha-chain variable (TCRAV) and T-cell receptor beta-chain variable (TCRBV) region repertoires in peripheral bloods from patients with myelodysplastic syndrome (MDS) with erythroid hypoplasia. T-cells bearing TCR ADV14S1/BV5S2, AV21S1/BV21S4, and AV2S2/BV7S2 segments were markedly increased in three of four MDS patients, respectively. In addition, there was a positive relationship between the increase in the number of CD8-positive T-cells and the expression levels of these TCR transcripts. These findings suggest that CD8-positive T-cells monoclonally or oligoclonally expanded in the peripheral blood. We also determined the nucleotide and amino acid sequences of the complementarity-determining region 3 (CDR3) of TCR alpha- and beta-chains of the expanded T-cells. Unique sequences were detected in a high percentage of the respective CDR3 clones. The gene segment of the variable and joining regions, however, varied among the patients. The deduced amino acid sequences of CDR3 were heterogeneous among the patients, and there was no common motif. These results indicate there is monoclonal or oligoclonal proliferation of CD8-positive T-cells in MDS patients with erythroid hypoplasia, and suggest that these proliferating T-cells are responsible for the pathogenesis of the MDS entity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12531221     DOI: 10.1016/s0145-2126(02)00173-x

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

1.  Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome.

Authors:  Marcin W Wlodarski; Lukasz P Gondek; Zachary P Nearman; Magdalena Plasilova; Matt Kalaycio; Eric D Hsi; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2006-04-13       Impact factor: 22.113

Review 2.  Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes.

Authors:  I Gañán-Gómez; Y Wei; D T Starczynowski; S Colla; H Yang; M Cabrero-Calvo; Z S Bohannan; A Verma; U Steidl; G Garcia-Manero
Journal:  Leukemia       Date:  2015-03-12       Impact factor: 11.528

Review 3.  Response to cyclosporine therapy in patients with myelodysplastic syndrome: a clinical study of 12 cases and literature review.

Authors:  Masao Ogata; Eiichi Ohtsuka; Tomoyuki Imamura; Junji Ikewaki; Yuko Ogata; Kazuhiro Kohno; Toshiyuki Nakayama; Keiji Ono; Yoshio Saburi; Hiroshi Kikuchi; Masaru Nasu
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

4.  Diversity and shared T-cell receptor repertoire analysis in esophageal squamous cell carcinoma.

Authors:  Tomoya Sudo; Akihiko Kawahara; Kazuo Ishi; Atsushi Mizoguchi; Sachiko Nagasu; Masashi Nakagawa; Masahiro Fujisaki; Haruhiro Hino; Kouhei Saisho; Hideaki Kaku; Satoru Matono; Naoki Mori; Jun Akiba; Akira Yamada; Yoshito Akagi
Journal:  Oncol Lett       Date:  2021-06-24       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.